Clinical Trial

Comparing the Efficacy of Different Durations of Maribavir Treatment Regimens in Allo-HSCT

Name: Comparing the Efficacy of Different Durations of Maribavir Treatment Regimens in Allo-HSCT — clinical trial record (NCT07511127)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

To comparing the efficacy of different durations of Maribavir treatment regimens in patients suffering from refractory CMV infection after allo-HSCT.

Trial Details

NCT Number	NCT07511127
Lead Sponsor	Ruijin Hospital
Conditions	Hematologic Malignancy
Enrollment	218 participants
Start Date	2026-02-28
Primary Completion	2027-12-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-06